ArticleDrug design, development and therapy2026
Diallyl Disulfide Mitigates LPS-Induced Inhibition of Osteogenic Differentiation and Alleviates Inflammatory Bone Loss via PI3K/AKT Signaling Pathway.
Jinze Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.